£50.17

Springer Current Hypotheses and Research Milestones in Alzheimer's Disease

Price data last checked 46 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 45 days • 45 data points (No recent data available)

Historical
Generating forecast...
£108.49 £43.89 £57.98 £72.08 £86.17 £100.27 £114.36 25 January 2026 05 February 2026 16 February 2026 27 February 2026 10 March 2026

Price Distribution

Price distribution over 45 days • 6 price levels

Days at Price
Current Price
13 days · current 5 days 1 day 4 days 3 days 19 days 0 5 10 14 19 £50 £56 £58 £62 £75 £108 Days at Price

Price Analysis

Most common price: £108 (19 days, 42.2%)

Price range: £50 - £108

Price levels: 6 different prices over 45 days

Description

Product Description Almost four decades of innovative and intensive research on Alzheimer’s disease (AD) have brought major advances in our understanding of its pathogenesis, improved tools for diagnosis, and strategies for its treatment. This research has helped build a solid foundation of knowledge in the neurosciences and biological basis of AD and AD-related neurological disorders. Scientific background and insightful hypotheses are of major relevance in order to approach to an effective therapy for this devastating disease. Current Hypotheses and Research Milestones in Alzheimer's Disease contains 20 seminal chapters by authors with varying views on the neuroanatomical, neuropathological, neuropsychological, neurological, and molecular aspects of AD. These chapters grew out of “Current Hypothesis on Alzheimer’s Disease”, held in Viña del Mar, Chile, in November of 2007. Participants included the world’s leading Alzheimer’s researchers, whose work has illuminated AD investigations during the past few decades. Students, academics and medical professionals will find this text an invaluable addition to the study of this important subject. From the Back Cover Almost four decades of innovative and intensive research on Alzheimer's disease (AD) have brought major advances in our understanding of its pathogenesis, while improving tools for diagnosis and developing strategies for its treatment. This research has helped build a solid foundation of knowledge in the neurosciences and biological basis of AD and AD-related neurological disorders. Current Hypotheses and Research Milestones in Alzheimer's Disease contains 20 seminal chapters by authors with varying views on the neuroanatomical, neuropathological, neuropsychological, neurological, and molecular aspects of AD, and offers the scientific background and insightful hypotheses needed to create an effective therapy for this devastating disease. These chapters grew out of "Current Hypothesis on Alzheimer’s Disease," held in Viña del Mar, Chile, in November of 2007. Participants included the world’s leading Alzheimer’s researchers, whose work have illuminated AD investigations during the past few decades. Students, academics and medical professionals will find this text an invaluable addition to the study of this important subject.   About the Authors: Ricardo B. Maccioni, Ph.D. is a Professor of Neurology at the Medical School and the Department of Biology, Faculty of Sciences, at the University of Chile. He also serves as the Director of the Laboratory of Molecular Neurosciences and Scientific Director of the International Center for Biomedicine (ICC). Dr. Maccioni received his doctoral degree in 1975 from the University of Chile, and served as a postdoctoral fellow at the University of Colorado Medical Center in Denver Colorado. He has made several major contributions to the the study of Alzheimer’s disease, including his discoveries on the role of tau protein and neuroimmunomodulation in the pathogenesis of this disease, and the design of new in vivo imaging technology and the novel biomarkers for its early diagnosis. He has received more than 60 research grants and several international and national prizes, including the Presidential Chair in Science, the Chancellor´s medal of the University of Chile, and Doctor Honris causa at several universities. Dr. Macconi has organized over forty international conferences with experts in the neurosciences from around the world. George Perry, Ph.D. is the Dean of the College of Sciences at The University of Texas at San Antonio. Dr. Perry received his doctoral degree in marine biology from the Scripps Institution of Oceanography at the University of California at San Diego, served as a postdoctoral fellow in cell biology at Baylor College of Medicine, and earned a bachelor's degree in zoology from the University of California at Santa Barbara. He is an authority on Alzheimer’s research, and his groundbreaking work

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
25 March 2009
Listed Since
01 September 2008

Barcode

No barcode data available

Similar Products You Might Like

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
95% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£207.59 10 Feb 2026
Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)
95% match

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)

Springer

£165.89 18 Apr 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
95% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.02 09 Mar 2026
Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1
95% match

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

£85.57 01 Mar 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
94% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Mar 2026
Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies
94% match

Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies

Academic Press

£57.02 27 Feb 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
94% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
94% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£13.02 28 Feb 2026
Early Detection of Alzheimer’s Disease: Biological and Technological Advances
94% match

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

Academic Press

£102.26 10 Mar 2026
Alzheimer's Disease Research Guide: Animal Models for Understanding Mechanisms and Medications
94% match

Alzheimer's Disease Research Guide: Animal Models for Understanding Mechanisms and Medications

£105.45 13 Jan 2026
Molecular Mechanisms of Dementia: Biomarkers, Neurochemistry, and Therapy
94% match

Molecular Mechanisms of Dementia: Biomarkers, Neurochemistry, and Therapy

Academic Press

£98.89 08 Mar 2026
Research Progress in Alzheimer's Disease & Dementia: Volume 6
94% match

Research Progress in Alzheimer's Disease & Dementia: Volume 6

£96.14 02 Mar 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
94% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£169.22 22 Jan 2026
Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)
94% match

Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)

Springer

£123.23 16 Apr 2026
Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)
94% match

Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)

Springer

£122.05 09 Mar 2026
Adenosine Receptors in Neurodegenerative Diseases
94% match

Adenosine Receptors in Neurodegenerative Diseases

Academic Press

£90.89 09 Feb 2026
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
94% match

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Academic Press

£120.98 30 Jan 2026
Neuroprotection in Alzheimer's Disease
94% match

Neuroprotection in Alzheimer's Disease

Academic Press

£85.71 11 Mar 2026
The Neuroscience of Dementia
94% match

The Neuroscience of Dementia

Academic Press

£212.79 24 Jan 2026
Neurodegeneration: Methods and Protocols: 793 (Methods in Molecular Biology, 793)
94% match

Neurodegeneration: Methods and Protocols: 793 (Methods in Molecular Biology, 793)

Humana

£102.16 26 Feb 2026
The Neuroscience of Aging
94% match

The Neuroscience of Aging

Academic Press

£279.70 11 Apr 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
94% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 23 Feb 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
94% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£24.24 24 Feb 2026
The Neurobiology of Aging and Alzheimer Disease in Down Syndrome
94% match

The Neurobiology of Aging and Alzheimer Disease in Down Syndrome

Academic Press

£101.99 07 Mar 2026